Published in Korean J Ophthalmol on July 21, 2016
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea (1998) 2.86
Utility assessment among patients with dry eye disease. Ophthalmology (2003) 2.71
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea (2009) 1.96
Mechanisms of action of cyclosporine. Immunopharmacology (2000) 1.81
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest (1994) 1.81
Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci (2011) 1.81
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci (2000) 1.74
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci (2005) 1.55
Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev (2009) 1.53
Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum (2004) 1.36
Utility assessment to measure the impact of dry eye disease. Ocul Surf (2006) 1.27
Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol (2010) 1.22
Biological therapies in the spondyloarthritides--the current state. Rheumatology (Oxford) (2004) 1.19
Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation. Ann Rheum Dis (2008) 1.03
PERSIST: Physician's Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review. Clin Ophthalmol (2012) 0.89
Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye. Invest Ophthalmol Vis Sci (2013) 0.83
Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice. Mol Med Rep (2014) 0.81
Adverse reactions of biological therapy for psoriasis. Rev Med Chir Soc Med Nat Iasi (2015) 0.79
Current practice pattern for dry eye patients in South Korea: a multicenter study. Korean J Ophthalmol (2014) 0.78
The korean social life, health and aging project-health examination cohort. Epidemiol Health (2014) 0.83
Activation of Dll4/Notch Signaling and Hypoxia-Inducible Factor-1 Alpha Facilitates Lymphangiogenesis in Lacrimal Glands in Dry Eye. PLoS One (2016) 0.76
Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities. Invest Ophthalmol Vis Sci (2014) 0.76
Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival. J Leukoc Biol (2016) 0.75
Patient Awareness of Cataract and Age-related Macular Degeneration among the Korean Elderly: A Population-based Study. Korean J Ophthalmol (2017) 0.75